Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?
Identifieur interne : 001D49 ( Main/Corpus ); précédent : 001D48; suivant : 001D50Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?
Auteurs : Petra Schwingenschuh ; Petra Katschnig ; Ronald Saurugg ; Erwin Ott ; Kailash P. BhatiaSource :
- Movement Disorders [ 0885-3185 ] ; 2010-03-15.
English descriptors
- KwdEn :
Abstract
A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of at‐risk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factors—young age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorder—engagement in a creative or artistic profession may be an additional risk factor for developing DDS. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22936
Links to Exploration step
ISTEX:6FF27A706233439DA81DD3F98B31E3A99CFA8467Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title><author><name sortKey="Schwingenschuh, Petra" sort="Schwingenschuh, Petra" uniqKey="Schwingenschuh P" first="Petra" last="Schwingenschuh">Petra Schwingenschuh</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Katschnig, Petra" sort="Katschnig, Petra" uniqKey="Katschnig P" first="Petra" last="Katschnig">Petra Katschnig</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Saurugg, Ronald" sort="Saurugg, Ronald" uniqKey="Saurugg R" first="Ronald" last="Saurugg">Ronald Saurugg</name><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Ott, Erwin" sort="Ott, Erwin" uniqKey="Ott E" first="Erwin" last="Ott">Erwin Ott</name><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6FF27A706233439DA81DD3F98B31E3A99CFA8467</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.22936</idno><idno type="url">https://api.istex.fr/document/6FF27A706233439DA81DD3F98B31E3A99CFA8467/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001D49</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title><author><name sortKey="Schwingenschuh, Petra" sort="Schwingenschuh, Petra" uniqKey="Schwingenschuh P" first="Petra" last="Schwingenschuh">Petra Schwingenschuh</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Katschnig, Petra" sort="Katschnig, Petra" uniqKey="Katschnig P" first="Petra" last="Katschnig">Petra Katschnig</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Saurugg, Ronald" sort="Saurugg, Ronald" uniqKey="Saurugg R" first="Ronald" last="Saurugg">Ronald Saurugg</name><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Ott, Erwin" sort="Ott, Erwin" uniqKey="Ott E" first="Erwin" last="Ott">Erwin Ott</name><affiliation><mods:affiliation>Department of Neurology, Medical University Graz, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name><affiliation><mods:affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-03-15">2010-03-15</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="493">493</biblScope><biblScope unit="page" to="496">496</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6FF27A706233439DA81DD3F98B31E3A99CFA8467</idno><idno type="DOI">10.1002/mds.22936</idno><idno type="ArticleID">MDS22936</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>DDS</term><term>Parkinson's disease</term><term>artists</term><term>creativity</term><term>dopamine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of at‐risk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factors—young age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorder—engagement in a creative or artistic profession may be an additional risk factor for developing DDS. © 2010 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Petra Schwingenschuh MD</name><affiliations><json:string>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</json:string><json:string>Department of Neurology, Medical University Graz, Graz, Austria</json:string></affiliations></json:item><json:item><name>Petra Katschnig MD</name><affiliations><json:string>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</json:string><json:string>Department of Neurology, Medical University Graz, Graz, Austria</json:string></affiliations></json:item><json:item><name>Ronald Saurugg MD</name><affiliations><json:string>Department of Neurology, Medical University Graz, Graz, Austria</json:string></affiliations></json:item><json:item><name>Erwin Ott MD</name><affiliations><json:string>Department of Neurology, Medical University Graz, Graz, Austria</json:string></affiliations></json:item><json:item><name>Kailash P. Bhatia MD</name><affiliations><json:string>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>artists</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>creativity</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>DDS</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dopamine</value></json:item></subject><articleId><json:string>MDS22936</json:string></articleId><language><json:string>eng</json:string></language><abstract>A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of at‐risk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factors—young age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorder—engagement in a creative or artistic profession may be an additional risk factor for developing DDS. © 2010 Movement Disorder Society</abstract><qualityIndicators><score>6.728</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>973</abstractCharCount><pdfWordCount>11560</pdfWordCount><pdfCharCount>74730</pdfCharCount><pdfPageCount>19</pdfPageCount><abstractWordCount>144</abstractWordCount></qualityIndicators><title>Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title><genre><json:string>article</json:string></genre><host><volume>25</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>4</total><last>496</last><first>493</first></pages><issn><json:string>0885-3185</json:string></issn><issue>4</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1002/mds.22936</json:string></doi><id>6FF27A706233439DA81DD3F98B31E3A99CFA8467</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/6FF27A706233439DA81DD3F98B31E3A99CFA8467/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/6FF27A706233439DA81DD3F98B31E3A99CFA8467/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/6FF27A706233439DA81DD3F98B31E3A99CFA8467/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2010</date></publicationStmt><notesStmt><note type="content">*Potential conflict of interest: Nothing to report.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title><author><persName><forename type="first">Petra</forename><surname>Schwingenschuh</surname></persName><roleName type="degree">MD</roleName><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</affiliation><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation></author><author><persName><forename type="first">Petra</forename><surname>Katschnig</surname></persName><roleName type="degree">MD</roleName><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</affiliation><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation></author><author><persName><forename type="first">Ronald</forename><surname>Saurugg</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation></author><author><persName><forename type="first">Erwin</forename><surname>Ott</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation></author><author><persName><forename type="first">Kailash P.</forename><surname>Bhatia</surname></persName><roleName type="degree">MD</roleName><note type="correspondence"><p>Correspondence: Sobell Department, Institute of Neurology, UCL, Queen Square, London WC1N 3BG, United Kingdom</p></note><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-03-15"></date><biblScope unit="volume">25</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="493">493</biblScope><biblScope unit="page" to="496">496</biblScope></imprint></monogr><idno type="istex">6FF27A706233439DA81DD3F98B31E3A99CFA8467</idno><idno type="DOI">10.1002/mds.22936</idno><idno type="ArticleID">MDS22936</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of at‐risk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factors—young age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorder—engagement in a creative or artistic profession may be an additional risk factor for developing DDS. © 2010 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>artists</term></item><item><term>creativity</term></item><item><term>DDS</term></item><item><term>dopamine</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-08-25">Received</change><change when="2009-11-08">Registration</change><change when="2010-03-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/6FF27A706233439DA81DD3F98B31E3A99CFA8467/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/mds.v25:4</doi><numberingGroup><numbering type="journalVolume" number="25">25</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="2010-03-15">15 March 2010</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="160" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22936</doi><idGroup><id type="unit" value="MDS22936"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2009-08-25"></event><event type="manuscriptRevised" date="2009-10-19"></event><event type="manuscriptAccepted" date="2009-11-08"></event><event type="firstOnline" date="2010-01-08"></event><event type="publishedOnlineFinalForm" date="2010-03-16"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-01-08"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.5.2 mode:FullText" date="2011-08-12"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">493</numbering><numbering type="pageLast">496</numbering></numberingGroup><correspondenceTo>Sobell Department, Institute of Neurology, UCL, Queen Square, London WC1N 3BG, United Kingdom</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22936.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="18"></count><count type="wordTotal" number="2214"></count></countGroup><titleGroup><title type="main" xml:lang="en">Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?<link href="#fn1"></link></title><title type="short" xml:lang="en">Artists and DDS</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Petra</givenNames><familyName>Schwingenschuh</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Petra</givenNames><familyName>Katschnig</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Ronald</givenNames><familyName>Saurugg</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Erwin</givenNames><familyName>Ott</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Kailash P.</givenNames><familyName>Bhatia</familyName><degrees>MD</degrees></personName><contactDetails><email>k.bhatia@ion.ucl.ac.uk</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="GB" type="organization"><unparsedAffiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="AT" type="organization"><unparsedAffiliation>Department of Neurology, Medical University Graz, Graz, Austria</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">artists</keyword><keyword xml:id="kwd3">creativity</keyword><keyword xml:id="kwd4">DDS</keyword><keyword xml:id="kwd5">dopamine</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of at‐risk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factors—young age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorder—engagement in a creative or artistic profession may be an additional risk factor for developing DDS. © 2010 Movement Disorder Society</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Potential conflict of interest: Nothing to report.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Artists and DDS</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?</title></titleInfo><name type="personal"><namePart type="given">Petra</namePart><namePart type="family">Schwingenschuh</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</affiliation><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Petra</namePart><namePart type="family">Katschnig</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</affiliation><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ronald</namePart><namePart type="family">Saurugg</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Erwin</namePart><namePart type="family">Ott</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Medical University Graz, Graz, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kailash P.</namePart><namePart type="family">Bhatia</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL, Queen Square, London, United Kingdom</affiliation><description>Correspondence: Sobell Department, Institute of Neurology, UCL, Queen Square, London WC1N 3BG, United Kingdom</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2010-03-15</dateIssued><dateCaptured encoding="w3cdtf">2009-08-25</dateCaptured><dateValid encoding="w3cdtf">2009-11-08</dateValid><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">18</extent><extent unit="words">2214</extent></physicalDescription><abstract lang="en">A small proportion of patients with Parkinson's disease (PD) develop a dopamine dysregulation syndrome (DDS). Management of such patients can be difficult; hence, early identification and careful monitoring of at‐risk individuals are important. Based on four illustrative cases, we wish to draw attention to the risk of developing DDS in PD patients engaged in a creative and artistic profession, who compulsively abuse dopaminergic drugs to maintain or enhance their artistic creativity. Balancing the drug requirement for treating motor symptoms on one hand and improving creativity on the other hand has to be carefully evaluated and early neuropsychiatric intervention may be necessary. Apart from the known risk factors—young age at PD onset, male gender, heavy alcohol consumption, illegal drug use, and history of affective disorder—engagement in a creative or artistic profession may be an additional risk factor for developing DDS. © 2010 Movement Disorder Society</abstract><note type="content">*Potential conflict of interest: Nothing to report.</note><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>artists</topic><topic>creativity</topic><topic>DDS</topic><topic>dopamine</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>493</start><end>496</end><total>4</total></extent></part></relatedItem><identifier type="istex">6FF27A706233439DA81DD3F98B31E3A99CFA8467</identifier><identifier type="DOI">10.1002/mds.22936</identifier><identifier type="ArticleID">MDS22936</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001D49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:6FF27A706233439DA81DD3F98B31E3A99CFA8467
|texte= Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?
}}
| This area was generated with Dilib version V0.6.23. |  |